Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Varying Degrees of Renal Insufficiency and”

Showing 14 of 0 results

Early research (Phase 1)Ended earlyNCT02508740
What this trial is testing

Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment

Who this might be right for
Renal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 31
Early research (Phase 1)Study completedNCT04154670
What this trial is testing

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

Who this might be right for
HealthyRenal Insufficiency
Ensoma 23
Early research (Phase 1)Study completedNCT04865393
What this trial is testing

Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

Who this might be right for
Renal Impairment
Spero Therapeutics 37
Early research (Phase 1)Study completedNCT04178447
What this trial is testing

Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function

Who this might be right for
Renal Impairment
Zealand Pharma 16
Early research (Phase 1)Study completedNCT05497297
What this trial is testing

Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Haisco Pharmaceutical Group Co., Ltd. 42
Early research (Phase 1)Study completedNCT01929109
What this trial is testing

LY2409021 in Participants With Different Levels of Kidney Function

Who this might be right for
Kidney Failure, ChronicRenal Insufficiency, Chronic
Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT04859439
What this trial is testing

Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00721734
What this trial is testing

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Who this might be right for
Multiple MyelomaRenal Insufficiency
Amgen 50
Early research (Phase 1)Study completedNCT01319266
What this trial is testing

Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment

Who this might be right for
Renal Impairment
Cephalon 55
Early research (Phase 1)Study completedNCT05283746
What this trial is testing

Epetraborole Tablets in Subjects With Degrees of Renal Function

Who this might be right for
Renal Insufficiency
AN2 Therapeutics, Inc 40
Early research (Phase 1)Study completedNCT02020434
What this trial is testing

The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency

Who this might be right for
Subjects With Varying Degrees of Renal Insufficiency andSubjects With Normal Renal Function
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 32
Early research (Phase 1)Study completedNCT02431481
What this trial is testing

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

Who this might be right for
Normal Renal FunctionImpaired Renal Function
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT00759564
What this trial is testing

Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function

Who this might be right for
Pneumonia
Pfizer 29
Early research (Phase 1)Study completedNCT07033182
What this trial is testing

Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment

Who this might be right for
Infections Caused by Anaerobic BacteriaRenal Impairment
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd 24

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation